Evidence map›Paper›PMID 22398245›Full record

ArticleClinical and vaccine immunology : CVI2012

Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Rajeev Rudraraju, Sherri L Surman, Bart G Jones, Robert Sealy, David L Woodland, Julia L Hurwitz

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nuclear Receptors, Ligands and the Mammalian B Cell.International journal of molecular sciences · 2020
    Review
  13. Role of Vitamins A and D in BCR-ABL ArfScientific reports · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rajeev RudrarajuDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Sherri L Surman
Bart G Jones
Robert Sealy
David L Woodland
Julia L Hurwitz
St. Jude Children's Research Hospital · USTrudeau Institute · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GERARD PAUL ZAMBETTI · 1985 to 2026
$166.9M
Recombinant Sendai Virus as Novel Paramyxovirus VaccineP01AI054955 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PORTNER, ALLEN · 2004 to 2008
$3.7M
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccineR01AI088729 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DEVINCENZO, JOHN P., HURWITZ, JULIA L · 2010 to 2014
$3.0M
Regulation of memory CD8+ T cell recruitment to the lungR01AI076499 · NIAID · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A · 2008 to 2012
$2.3M
NCI NIH HHS P30 CA021765NCI NIH HHS P30-CA21765NIAID NIH HHS P01 AI054955NIAID NIH HHS R01 AI076499NIAID NIH HHS R01 AI088729
6 · The paper itself

Abstract

Vitamin A deficiency (VAD) has profound effects on immune responses in the gut, but its effect on other mucosal responses is less well understood. Sendai virus (SeV) is a candidate human parainfluenza virus type 1 (hPIV-1) vaccine and a candidate vaccine vector for other respiratory viruses. A single intranasal dose of SeV elicits a protective immune response against hPIV-1 within days after vaccination. To define the effect of VAD on acute responses toward SeV, we monitored both antibodies and CD8(+) T cells in mice. On day 10 following SeV infection, there was a trend toward lower antibody activities in the nasal washes of VAD mice than in those of controls, while bronchoalveolar lavage (BAL) fluid and serum antibodies were not reduced. In contrast, there was a dramatic reduction of immunodominant CD8(+) T cell frequencies in the lower respiratory tract (LRT) airways of VAD animals. These T cells also showed unusually high CD103 (the αE subunit of αEβ7) expression patterns. In both VAD and control mice, E-cadherin (the ligand for αEβ7) was better expressed among epithelial cells lining the upper respiratory tract (URT) than in LRT airways. The results support a working hypothesis that the high CD103 expression among T cell populations in VAD mice alters mechanisms of T cell cross talk with URT and LRT epithelial cells, thereby inhibiting T cell migration and egress into the lower airway. Our data emphasize that the consequences of VAD are not limited to gut-resident cells and characterize VAD influences on an immune response to a respiratory virus vaccine.

Indexed as

AnimalsAntibodies, ViralBloodBronchoalveolar Lavage FluidCD8-Positive T-LymphocytesEndoglinEpithelial CellsFemaleImmunophenotypingIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLNasal MucosaPregnancyRespiratory SystemSendai virusAntibodies, ViralEndoglinEng protein, mouseIntracellular Signaling Peptides and Proteins

Identifiers

PMID22398245
PMCPMC3346339
OpenAlexW2121121305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.